$RHHBY strikes obesity drug licensing deal with China's Rona Therapeutics
- Deal worth up to $1.16B
- Roche gains rights to Rona's obesity pipeline asset
- Signals Roche's continued push into the weight-loss drug race
#obesity#RHHBY
Roche'dan 7,1 milyar dolarlık satın alma.
İsviçreli ilaç şirketi Roche, inflamatuar bağırsak hastalıkları için ilaçlar geliştiren Telavant Holding'i 7,1 milyar dolara satın almak üzere anlaşmaya varıldığını duyurdu.
-Bloomberg
#ABD#RHHBY#PFE#ROIV#Yatırım#Satınalma
We are pleased to announce the FDA’s decision to grant Emergency Use Authorization for our at-home rapid antigen test, supporting individuals and the American public’s fight against #COVID19. Learn more: bit.ly/33TYfyZ#ROG#RHHBY
#MEDIA - Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases: bit.ly/3zZE3H0#RHHBY#ROG
We're maintaining our fair value estimates for #Roche (#RHHBY) and for #Regeneron (REGN) following data from a trial of the SARS-CoV-2 antibody cocktail. This cocktail has been taken by President #Trump. spr.ly/6011GL7lf#covid
Roche to launch instrument-free SARS-CoV-2 Rapid Antigen Test enabling convenient use for healthcare professionals at different point of care locations. Learn more: go.roche.com/ag-tw#ROG#RHHBY#COVID19
Qualigen's FastPack® test uses a specific protein that is also used by major diagnostics companies including Abbott Laboratories, Roche Diagnostics and Bio-Rad Laboratories in their COVID-19 antibody tests. $QLGN$ABT#RHHBY#Coronavirus#AntibodyTeststreetinsider.com/Corporate+…
The Roche exec highlights its 2020 expected launches of risdiplam in SMA and satralizumab in NMOSD. Also highlights research efforts in Alzheimer's, Huntington's, Parkinson's and autism. #JPM20
Roche will acquire Ignyta, a California based company that is focused on precision medicine for rare cancer mutations: ow.ly/h9ah30ho6RH#ROG#RHHBY#RXDX